Endonovo Therapeutics Inc (ENDV)
0.0022
0.00 (0.00%)
USD |
OTCM |
May 06, 16:00
Endonovo Therapeutics Profit Margin (Quarterly): -26.80K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -26.80K% |
September 30, 2023 | -50.41K% |
June 30, 2023 | |
March 31, 2023 | |
December 31, 2022 | -10.65K% |
September 30, 2022 | -5.51K% |
June 30, 2022 | -388.6K% |
March 31, 2022 | -105.7K% |
December 31, 2021 | |
September 30, 2021 | -19.56K% |
June 30, 2021 | -4.28K% |
March 31, 2021 | -7.72K% |
December 31, 2020 | -17.65K% |
September 30, 2020 | -2.67K% |
June 30, 2020 | -3.66K% |
March 31, 2020 | |
December 31, 2019 | -3.82K% |
September 30, 2019 | -2.60K% |
June 30, 2019 | -12.49K% |
March 31, 2019 | -5.35K% |
December 31, 2018 | |
September 30, 2018 | -27.92K% |
June 30, 2018 | -9.73K% |
March 31, 2018 | -8.88K% |
Date | Value |
---|---|
December 31, 2017 | |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | -29.05K% |
March 31, 2015 | -17.49K% |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | -1.23K% |
March 31, 2014 | -3.54K% |
December 31, 2013 | -2.95K% |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | -5.49K% |
June 30, 2012 | -5.32K% |
March 31, 2012 | -25.75K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-388.6K%
Minimum
Jun 2022
-2.60K%
Maximum
Sep 2019
-44.15K%
Average
-10.65K%
Median
Dec 2022
Profit Margin (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | -110.2% |
Palatin Technologies Inc | -385.6% |
iBio Inc | -- |
Theriva Biologics Inc | -- |
Oragenics Inc | -- |
Profit Margin (Quarterly) Related Metrics
Return on Assets | 699.6% |
Gross Profit Margin (Quarterly) | 49.57% |
Operating Margin (Quarterly) | -13.14K% |